Showing 10 of 10 recruiting trials for “Sickle cell anemia”
Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
👨⚕️ Swee Lay Thein, M.D., National Heart, Lung, and Blood Institute (NHLBI)📍 1 site📅 Started Dec 2024View details ↗
Pressure Pain Tolerance in Relation to Balance and Strength in Children
👨⚕️ Shimaa A Ahmed, PHD, Head of Haematology Dept, Faculty of Medicine, Alexandria University📍 1 site📅 Started Feb 2024View details ↗
Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa
👨⚕️ Patrick T McGann, MD, MS, Rhode Island Hospital and Hasbro Children's Hospital📍 1 site📅 Started Nov 2023View details ↗
RecruitingNCT06250595 ↗
European Rare Blood Disorders Platform (ENROL)
👨⚕️ María del Mar Manú Pereira, PhD, Vall d'Hebron Institut de Recerca / University Hospital Vall d'Hebron (VHIR / HUVH)📍 1 site📅 Started Jul 2022View details ↗
A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD
👨⚕️ Selim Corbacioglu, MD, University Hospital of Regensburg📍 9 sites📅 Started Jun 2021View details ↗
A Long-term Follow-up Study in Participants Who Received CTX001
Stroke Prevention With Hydroxyurea Enabled Through Research and Education (SPHERE)
RecruitingNCT03685721 ↗
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
👨⚕️ Swee Lay Thein, M.D., National Heart, Lung, and Blood Institute (NHLBI)📍 1 site📅 Started Oct 2018View details ↗
T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →